Quoin Pharmaceuticals Ltd. Share-based Payment Arrangement, Noncash Expense
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- Quoin Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $532.95K, a 65.78% increase year-over-year.
- Quoin Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $444.52K, a 23.36% increase year-over-year.
- Quoin Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $283.20K, a 13.22% decline year-over-year.
- Quoin Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $182.19K, a 41.82% decline year-over-year.
- Quoin Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for fiscal 2025 was $1.15M, a 8.87% decline from fiscal 2024.
- Quoin Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for fiscal 2024 was $1.26M, a 15.01% increase from fiscal 2023.
- Quoin Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for fiscal 2023 was $1.09M, a 43.26% increase from fiscal 2022.
- Quoin Pharmaceuticals Ltd. share-based payment arrangement, noncash expense for fiscal 2022 was $764.01K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $532.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $977.48K 10-Q · filed 2026-08-14 | $1.26M derived: sum of 3 quarters · filed 2026-08-14 | $1.44M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $444.52K 10-Q · filed 2026-05-07 | $727.73K derived: sum of 2 quarters · filed 2026-05-07 | $909.92K derived: sum of 3 quarters · filed 2026-05-07 | $1.23M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $283.20K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $465.39K derived: sum of 2 quarters · filed 2026-03-26 | $786.88K derived: sum of 3 quarters · filed 2026-08-14 | $1.15M 10-K · filed 2026-03-26 |
| 2025-09-30 | $182.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $503.67K derived: sum of 2 quarters · filed 2026-08-14 | $864.03K 10-Q · filed 2025-11-06 | $1.19M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $321.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $681.84K 10-Q · filed 2026-08-14 | $1.01M derived: sum of 3 quarters · filed 2026-08-14 | $1.32M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $360.36K 10-Q · filed 2026-05-07 | $686.69K derived: sum of 2 quarters · filed 2026-05-07 | $999.81K derived: sum of 3 quarters · filed 2026-05-07 | $1.31M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $326.33K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $639.45K derived: sum of 2 quarters · filed 2026-03-26 | $952.58K derived: sum of 3 quarters · filed 2026-03-26 | $1.26M 10-K · filed 2026-03-26 |
| 2024-09-30 | $313.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $626.24K derived: sum of 2 quarters · filed 2025-11-06 | $932.56K 10-Q · filed 2025-11-06 | $1.23M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $313.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $619.44K 10-Q · filed 2025-08-07 | $919.63K derived: sum of 3 quarters · filed 2025-08-07 | $1.19M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $306.31K 10-Q · filed 2025-05-13 | $606.51K derived: sum of 2 quarters · filed 2025-05-13 | $875.01K derived: sum of 3 quarters · filed 2025-05-13 | $1.14M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $300.20K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $568.70K derived: sum of 2 quarters · filed 2025-03-13 | $833.08K derived: sum of 3 quarters · filed 2025-03-13 | $1.09M 10-K · filed 2025-03-13 |
| 2023-09-30 | $268.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $532.88K derived: sum of 2 quarters · filed 2024-11-08 | $794.35K 10-Q · filed 2024-11-08 | $1.06M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $264.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $525.85K 10-Q · filed 2024-08-08 | $793.13K derived: sum of 3 quarters · filed 2024-08-08 | $1.06M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $261.47K 10-Q · filed 2024-05-09 | $528.75K derived: sum of 2 quarters · filed 2024-05-09 | $796.04K derived: sum of 3 quarters · filed 2024-05-09 | |
| 2022-12-31 | $267.28K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $534.57K derived: sum of 2 quarters · filed 2024-03-14 | $764.01K 10-K · filed 2024-03-14 | |
| 2022-09-30 | $267.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $496.72K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $229.44K 10-Q · filed 2023-08-03 |